Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 17;9(7):1717.
doi: 10.3390/cells9071717.

Microglia: Agents of the CNS Pro-Inflammatory Response

Affiliations
Review

Microglia: Agents of the CNS Pro-Inflammatory Response

José A Rodríguez-Gómez et al. Cells. .

Abstract

The pro-inflammatory immune response driven by microglia is a key contributor to the pathogenesis of several neurodegenerative diseases. Though the research of microglia spans over a century, the last two decades have increased our understanding exponentially. Here, we discuss the phenotypic transformation from homeostatic microglia towards reactive microglia, initiated by specific ligand binding to pattern recognition receptors including toll-like receptor-4 (TLR4) or triggering receptors expressed on myeloid cells-2 (TREM2), as well as pro-inflammatory signaling pathways triggered such as the caspase-mediated immune response. Additionally, new research disciplines such as epigenetics and immunometabolism have provided us with a more holistic view of how changes in DNA methylation, microRNAs, and the metabolome may influence the pro-inflammatory response. This review aimed to discuss our current knowledge of pro-inflammatory microglia from different angles, including recent research highlights such as the role of exosomes in spreading neuroinflammation and emerging techniques in microglia research including positron emission tomography (PET) scanning and the use of human microglia generated from induced pluripotent stem cells (iPSCs). Finally, we also discuss current thoughts on the impact of pro-inflammatory microglia in neurodegenerative diseases.

Keywords: TLR4; TREM2; caspases; epigenetics; iPSCs; inflammation; metabolomics; microglia.

PubMed Disclaimer

Conflict of interest statement

E.K. is a consultant for Cerevance Ltd. The other authors declare no conflict of interest.

Figures

Figure 1
Figure 1
TLR4 signaling pathways activated in microglia during neuroinflammation. (A) LPS binding to TLR4 triggers sequential activation of caspase-8 and caspase-3 with nuclear translocation of NF-κB and expression of genes involved in inflammatory response. The molecular mechanism triggering activation of caspase-8 is unknown at the moment. LPS can also activate the expression of inflammatory genes by means of (B) the MyD88-dependent pathway or (C) the TIR-domain containing adapter-inducing interferon-γ (TRIF)-dependent pathway with receptor-interacting protein kinase 1 (RIPK1) ubiquitination. (D) Although not clearly defined in microglia, under deubiquitinating conditions, RIPK1 can form a ripoptosome-like complex that ultimately leads to necrosome formation and necroptotic cell death with release of DAMPs. (E) TLR4-mediated increase in gene expression of NOD-, LRR- and pyrin domain-containing protein (NLRP3), pro-IL-1β, and pro-IL-18 is the priming stage of inflammasome formation. In the activation stage, the assembly of inflammasome complex activates caspase-1, which allows the maturation of IL-1β and IL-18 and their release through pyroptosis. (F) A noncanonical inflammasome has been also described in microglia that gives rise to caspase-8 activation and IL-1β maturation and release.
Figure 2
Figure 2
Schematic representation of epigenetic control of the inflammatory response in microglia. (A) SIRT1 deacetylates and activates DNMT1, provoking IL-1β repression through DNA methylation. TET2 regulates the expression of genes related to type I interferon response and glucose metabolism independently of its enzymatic activity, most likely acting as a scaffold for other proteins in gene promoter regions. (B) The histone methylase EZH2 and the histone demethylase JMJD3 increase or decrease the pro-inflammatory response respectively through H3K27 methylation/demethylation (once H3K27 is demethylated it becomes acetylated by CBP/P300). The use of HDACi such as TSA, VPA, SAHA, or SB, or the decrease in expression in HDAC1 and HDAC2 decreases the pro-inflammatory response and increases microglial phagocytic capacity. SIRT1 interacts with hMOF, resulting in the deacetylation and activation of hMOF, which then acetylates H4K16 and promotes the tumor-supportive microglial phenotype. (C) MiRs regulate the microglial inflammatory response. MiRs are transcribed and processed in the nucleus into pri-miR and pre-miR, which are then translocated to the cytosol with the aid of Ran-GTP/exportin 5. Once in the cytosol, pre-miR becomes miR through processing mediated by DICER/TRBP/AGO2. Finally, miR targets mRNA, forming a miRISC complex, which provokes either mRNA degradation or inhibits translation of the targeted genes. MiR-365, miR-125b and miR155 promote a pro-inflammatory response while miR-Let7a and miR-Let7c inhibit it. Also, miR-155 inhibits phagocytosis while miR-124 promotes it.
Figure 3
Figure 3
Overview of metabolic alterations in microglia metabolic pathways associated with the four immunometabolites (yellow boxes): Itaconate, tryptophan, arginine, and glutamine in microglia. Metabolic changes in itaconate observed in macrophages and the TCA cycle (dotted line) include activation of NRF2/ATF3, inhibition of SDH as well as stabilization of HIF1α, production of IL-1β, and increased OxPHOS through succinate accumulation as well as inhibition of glycolysis through citrate. Tryptophan catabolism results in the conversion of tryptophan to kynurinene by IDO and the production of kynurenic acid or 3-hydroxykynurinene, the latter of which produces quinolinic acid with neurotoxic effects. Arginine catabolism is illustrated by either the generation of ornithine by ARG1, ultimately leading to polyamine production used for repair and wound healing, or production of citrulline and NO by NOS2. NO effectively inhibits OxPHOS. Glutamine results in mTOR activation and is converted to glutamate through GLS. Glutamate is further metabolized by GDH to form one of the principal components of the TCA cycle: α-ketoglutarate.

Similar articles

Cited by

References

    1. Ramón y Cajal S. Contribución al Conocimiento de la Neuroglía del Cerebro Humano. Trab. Lab. Invest. Biol. Univ. Madrid. 1913;XI:215–315.
    1. Río-Hortega P. Estudios sobre la neuroglía. La microglía y su transformación en células en bastoncito y cuerpos gránulo-adiposos. Trab. Lab. Invest. Biol. Univ. Madrid. 1920;18:37–82.
    1. Río-Hortega P. El “tercer elemento” de los centros nerviosos. I. La microglía en estado normal. Bol. Soc. Esp. Biol. 1919;VIII:67–82.
    1. Río-Hortega P. El Tercer Elemento de los Centros Nerviosos. II. Intervención de la Microglía en los Procesos Patológicos (Células en Bastoncito y Cuerpos Gránuloadiposos) Bol. Soc. Esp. Biol. 1919;VIII:91–103.
    1. Río-Hortega P. El “tercer elemento” de los centros nerviosos. III. Naturaleza probable de la microglía. Bol. Soc. Esp. Biol. 1919;VIII:108–121.

Publication types